Market Cap 52.73M
Revenue (ttm) 3.29M
Net Income (ttm) -15.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -465.65%
Debt to Equity Ratio 0.00
Volume 199,600
Avg Vol 221,238
Day's Range N/A - N/A
Shares Out 55.50M
Stochastic %K 6%
Beta 0.33
Analysts Strong Sell
Price Target $2.98

Company Profile

IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 623 0333
Fax: 972 4 623 0222
Address:
7 Ha’Eshel Street, PO Box 3163, Caesarea, Israel
Bucket_Head
Bucket_Head Jun. 20 at 5:46 PM
$ICCM What would the FDA approval do for the price action in conjunction with the offering? Thoughts?
0 · Reply
noonknight
noonknight Jun. 17 at 3:42 PM
$ICCM This offering/subscription pronouncement by ICCM is interesting. but it seems to be, at this time, up in the air: No dates of execution, no pricing, only the broad concept is being divulged now. Does anyone want to elaborate on this?
1 · Reply
SimpleTradingABC
SimpleTradingABC Jun. 17 at 2:02 AM
$ICCM I thought this was a good summary of the awesome possibilities of the rights offering from ICCM. Also, how it could turn into a magnet by
2 · Reply
SimpleTradingABC
SimpleTradingABC Jun. 16 at 4:51 PM
$ICCM After learning more ICCM is offering a rights offering and not dilution, it’s an invitation. They're giving loyal holders first access to shares at HALF PRICE + 5-yr warrants. If you're serious about ICCM, this is a rare opportunity to scale with max leverage before FDA clearance drops. More risk? Yes. But also, WAY more ROI if ICCM hits — and YOU get first dibs before the market. #biotech #riskreward #smallcaps #fda #ICCM
1 · Reply
Planetpaprika
Planetpaprika Jun. 16 at 3:02 PM
$ICCM is offering existing shareholders the right to buy new units (1 Ordinary Share + 1 Warrant to buy another share) at a fixed price (the Subscription Price), likely below market price, with: No cost to receive the rights. Non-transferable rights (you can’t sell them). Over-subscription privilege (if others don’t buy, you can buy more). Positive: Discounted Purchase: If the subscription price is lower than the market price, it's a bargain. Warrants Add Value: Warrants give you a future option to buy at a locked-in price. No Immediate Dilution If Participating: If you exercise your rights, you maintain your ownership percentage. Optional Participation: You can choose whether or not to invest more. Potential Negativ Dilution Risk: If you don’t participate, your ownership % is diluted. Non-transferable Rights: You can’t sell the rights if you don't want to use them, which is less favorable than transferable rights offerings. Signals Cash Need... All depending on the concrete numbers re offering IMO
1 · Reply
homeal
homeal Jun. 16 at 12:27 PM
$ICCM Thank you for sharing. Is it bad for us?
2 · Reply
MrTicker
MrTicker Jun. 16 at 12:19 PM
$ICCM Form F-1 IceCure Medical Ltd. 10K WIZARD 7:19 AM ET 6/16/2025 http://archive.fast-edgar.com/20250616/A92Z922CLZ22K9BB22JC2ZY2HJBDZ222Z672 Filed on: June 16, 2025
0 · Reply
MrTicker
MrTicker Jun. 16 at 11:19 AM
$ICCM Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), IceCure Medical Ltd. (the “Company”) hereby respectfully requests that the U.S. Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s registration statement on Form F-1 (File No. 333-282652), together with the exhibits and amendments thereto, which was initially filed with the Commission on October 15, 2024 (the “Registration Statement”), as of the date hereof or at the earliest practicable date hereafter.
1 · Reply
MrTicker
MrTicker Jun. 16 at 11:19 AM
$ICCM The Company has determined not to pursue, at this time, the public offering to which the Registration Statement relates. No securities were sold or will be sold under the Registration Statement. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477 under the Securities Act.
0 · Reply
MrTicker
MrTicker Jun. 16 at 11:18 AM
$ICCM Form RW IceCure Medical Ltd. 10K WIZARD 6:15 AM ET 6/16/2025 http://archive.fast-edgar.com/20250616/AC29K22CLZ22J9AB22JH2ZY2BS9CZ222Z272 Filed on: June 16, 2025
0 · Reply
Latest News on ICCM
IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript

May 28, 2025, 4:26 PM EDT - 23 days ago

IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript


IceCure Medical Reports First Quarter 2025 Financial Results

May 28, 2025, 8:30 AM EDT - 23 days ago

IceCure Medical Reports First Quarter 2025 Financial Results


IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 1:45 PM EDT - 3 months ago

IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript


IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 1:46 PM EST - 7 months ago

IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript


IceCure Medical Ltd (ICCM) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 3:29 PM EDT - 10 months ago

IceCure Medical Ltd (ICCM) Q2 2024 Earnings Call Transcript


IceCure Medical Ltd (ICCM) Q1 2024 Earnings Call Transcript

May 28, 2024, 5:06 PM EDT - 1 year ago

IceCure Medical Ltd (ICCM) Q1 2024 Earnings Call Transcript


Bucket_Head
Bucket_Head Jun. 20 at 5:46 PM
$ICCM What would the FDA approval do for the price action in conjunction with the offering? Thoughts?
0 · Reply
noonknight
noonknight Jun. 17 at 3:42 PM
$ICCM This offering/subscription pronouncement by ICCM is interesting. but it seems to be, at this time, up in the air: No dates of execution, no pricing, only the broad concept is being divulged now. Does anyone want to elaborate on this?
1 · Reply
SimpleTradingABC
SimpleTradingABC Jun. 17 at 2:02 AM
$ICCM I thought this was a good summary of the awesome possibilities of the rights offering from ICCM. Also, how it could turn into a magnet by
2 · Reply
SimpleTradingABC
SimpleTradingABC Jun. 16 at 4:51 PM
$ICCM After learning more ICCM is offering a rights offering and not dilution, it’s an invitation. They're giving loyal holders first access to shares at HALF PRICE + 5-yr warrants. If you're serious about ICCM, this is a rare opportunity to scale with max leverage before FDA clearance drops. More risk? Yes. But also, WAY more ROI if ICCM hits — and YOU get first dibs before the market. #biotech #riskreward #smallcaps #fda #ICCM
1 · Reply
Planetpaprika
Planetpaprika Jun. 16 at 3:02 PM
$ICCM is offering existing shareholders the right to buy new units (1 Ordinary Share + 1 Warrant to buy another share) at a fixed price (the Subscription Price), likely below market price, with: No cost to receive the rights. Non-transferable rights (you can’t sell them). Over-subscription privilege (if others don’t buy, you can buy more). Positive: Discounted Purchase: If the subscription price is lower than the market price, it's a bargain. Warrants Add Value: Warrants give you a future option to buy at a locked-in price. No Immediate Dilution If Participating: If you exercise your rights, you maintain your ownership percentage. Optional Participation: You can choose whether or not to invest more. Potential Negativ Dilution Risk: If you don’t participate, your ownership % is diluted. Non-transferable Rights: You can’t sell the rights if you don't want to use them, which is less favorable than transferable rights offerings. Signals Cash Need... All depending on the concrete numbers re offering IMO
1 · Reply
homeal
homeal Jun. 16 at 12:27 PM
$ICCM Thank you for sharing. Is it bad for us?
2 · Reply
MrTicker
MrTicker Jun. 16 at 12:19 PM
$ICCM Form F-1 IceCure Medical Ltd. 10K WIZARD 7:19 AM ET 6/16/2025 http://archive.fast-edgar.com/20250616/A92Z922CLZ22K9BB22JC2ZY2HJBDZ222Z672 Filed on: June 16, 2025
0 · Reply
MrTicker
MrTicker Jun. 16 at 11:19 AM
$ICCM Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), IceCure Medical Ltd. (the “Company”) hereby respectfully requests that the U.S. Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s registration statement on Form F-1 (File No. 333-282652), together with the exhibits and amendments thereto, which was initially filed with the Commission on October 15, 2024 (the “Registration Statement”), as of the date hereof or at the earliest practicable date hereafter.
1 · Reply
MrTicker
MrTicker Jun. 16 at 11:19 AM
$ICCM The Company has determined not to pursue, at this time, the public offering to which the Registration Statement relates. No securities were sold or will be sold under the Registration Statement. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477 under the Securities Act.
0 · Reply
MrTicker
MrTicker Jun. 16 at 11:18 AM
$ICCM Form RW IceCure Medical Ltd. 10K WIZARD 6:15 AM ET 6/16/2025 http://archive.fast-edgar.com/20250616/AC29K22CLZ22J9AB22JH2ZY2BS9CZ222Z272 Filed on: June 16, 2025
0 · Reply
GJ_Rockabilt
GJ_Rockabilt Jun. 15 at 4:52 PM
$ICCM What does curing Breast Cancer have to do with War? Very little. I'm out, for now. My Biotech #1 is HUMA , HUMAW. They have a history of treating war injuries.
0 · Reply
Tonyboner
Tonyboner Jun. 15 at 10:40 AM
$ICCM Israel is getting bombed to bits by Iran and is only ramping up. IceCure Medical Ltd 7 Ha’Eshel Street PO Box 3163 Caesarea, 3079504 Israel
1 · Reply
Tonyboner
Tonyboner Jun. 13 at 2:40 PM
$ICCM https://x.com/MonitorX99800/status/1933525372005712143
1 · Reply
Tonyboner
Tonyboner Jun. 13 at 2:38 PM
$ICCM I'm out , Israel about to get nuked this thing is heading to 20c
0 · Reply
zimi1954
zimi1954 Jun. 12 at 6:27 PM
$ICCM I'M out. Best of luck to all
1 · Reply
Planetpaprika
Planetpaprika Jun. 11 at 3:04 PM
$ICCM has received a Notice of Allowance for its 'Cryogen Flow Control' patent application from the United States Patent and Trademark Office. This patent, anticipated to be valid until 2045, represents a significant step in advancing the company's cryoablation technology. While the patent has already been secured in Japan, it is still pending in the European Union and other key global markets. The company's CEO highlighted that this technological innovation aims to enhance the efficiency of cryoablation procedures and broaden its application range. As IceCure Medical awaits the U.S. FDA's decision on their ProSense system, particularly for use in early-stage breast cancer treatment for women over 70 in combination with endocrine therapy, expanding their intellectual property is critical. The company positions itself as a leader in liquid nitrogen-based cryoablation, underlining its commitment to innovation and commercialization efforts. https://www.gurufocus.com/news/2915505/icecure-medical-iccm-secures-us-patent-for-cryogen-flow-control-iccm-stock-news
0 · Reply
inmarketswetrust
inmarketswetrust Jun. 10 at 2:10 AM
$ICCM first of all for the person that asked how long it takes the FDA to approve a “drug” ICCM’s prosense is up for approval under De Novo- for medical devices- to treat NIBC smaller than 1 cm. The newer version of the prosense machine is the X sense and that has 501K already.
0 · Reply
Bucket_Head
Bucket_Head Jun. 9 at 10:26 PM
$ICCM I believe that @Lirik has a very valid point!!
0 · Reply
MathiasMatheson
MathiasMatheson Jun. 9 at 8:31 PM
$ICCM According to the food and drug administration: 510k clearance takes place around the 5th of each month and generally around 90 days. Given that this device has already received clearance in Japan and is used elsewhere. Along with it's level of risk, one would expect the critical pathway to be relatively short. Maybe even soon enough to remedy the growth on the occipital lobe, affecting reading comprehension of my biggest critic.
0 · Reply
Lirik
Lirik Jun. 9 at 6:16 PM
$ICCM this guy is an absolute moron. He needs a block to the face.
1 · Reply
Bucket_Head
Bucket_Head Jun. 9 at 5:16 PM
$ICCM Its only a matter of a very short time...
0 · Reply
MathiasMatheson
MathiasMatheson Jun. 9 at 5:09 PM
$ICCM uhh the 13g puts the significant ownership at around 93%. Ironic. So how long does it take the fda to approve a a drug like this ?
1 · Reply